Palavra-chave: ANNEXIN A1

TISSUE ENGINEERING SKIN BIOLOGICAL SCAFFOLDS ANTI-INFLAMMATORY COMPOUNDS NEW DRUG SKIN ALLOGRAFT TUMORIGENESIS FPR1 TUMOR MICROENVIRONMENT KERATINOCYTES CANCER AGGRESSIVENESS DRUG DISCOVERY INFLAMMATION CATHEPSIN D PSORIASIS TRIPLE NEGATIVE BREAST CANCER PROTEASE INHIBITION NLRP3 INFLAMMASOME INTESTINAL DISEASES PHOSPHOLIPASE A2 SKIN REPLACEMENT SKIN DISEASES LIPID METABOLISM SKIN TRANSPLANTATION CYCLOSPORIN H ATOPIC DERMATITIS NEW PEPTIDE WOUND HEALING RESOLUTION OF INFLAMMATION CYCLOSPORIN A